MEF2C and hepatocellular carcinoma: In fact, in hepatocellular carcinoma, cytoplasmatic MEF2C inhibited malignant cell proliferation, whereas nuclear MEF2C was associated with increased malignancy through angiogenesis and tumor invasion [16].